# Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

> **NCT05324618** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 200 (actual)

## Conditions studied

- Atopic
- Dermatitis

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT05324618
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-15
- **Primary completion:** 2022-11-20
- **Final completion:** 2023-04-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324618, "Tacrolimus Versus Hydrocortisone in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05324618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*